LATEST
Report: 14 transactions
8 purchases and 6 sales dated 2 Sep 2022 to 6 Sep 2022, across 3 tickers. 3 tickers appear for the first time, including IDV, IJH, IWM.
What changed in the latest report
Each row is one posting date. Counts come from the rows Tracked Money read from that day's reports; "first time" means the ticker is in no earlier report.
2 reports: 5 transactions
4 purchases and 0 sales dated 3 Jan 2023 to 4 Jan 2023; none matched to a ticker. No ticker appears for the first time.
Report: 1 transaction
0 purchases and 1 sales dated 29 Dec 2022 to 29 Dec 2022; none matched to a ticker. No ticker appears for the first time.
2 reports: 1 transaction
0 purchases and 1 sales dated 27 Sep 2022 to 27 Sep 2022; none matched to a ticker. No ticker appears for the first time.
2 reports: 1 transaction
1 purchases and 0 sales dated 30 Aug 2022 to 30 Aug 2022; none matched to a ticker. No ticker appears for the first time.
When the trades happened
| Month | Trades |
|---|---|
| Oct 2021 | 143 |
| Nov 2021 | 0 |
| Dec 2021 | 0 |
| Jan 2022 | 0 |
| Feb 2022 | 0 |
| Mar 2022 | 0 |
| Apr 2022 | 0 |
| May 2022 | 1 |
| Jun 2022 | 3 |
| Jul 2022 | 1 |
| Aug 2022 | 1 |
| Sep 2022 | 15 |
| Oct 2022 | 0 |
| Nov 2022 | 0 |
| Dec 2022 | 1 |
| Jan 2023 | 5 |
Buying or selling?
BUY 14
155 SELL
What stocks does Remy own and trade most?
The 10 tickers traded most often in the reports. A 278-T lists transactions, not holdings, and gives sizes as ranges, so a count shows activity rather than position size. Select one to chart it below.
BuysSells
Trades against the share price
Weekly closing price for each of the most-traded stocks, with every buy (green) and sell (orange) placed at its trade date.
Ascendis Pharma A/S · weekly close0 buys · 14 sells · +40.1% since Oct 2021
BuySell
What if you had copied Remy's trades?
Put an amount in and choose when you would have entered each trade: on the day it happened, or on the day the report was posted, which is when you could first have seen it. Compared with the S&P 500 over the same days.
$
Enter on
Period
Copying Remy$12,579+25.8%
S&P 500$13,750+37.5%
$10,000 split equally across every disclosed buy (entered on its trade date, held until a disclosed sell), up to Mar 2024 (last filing) (6 Sep 2022 to 28 Mar 2024).
How Remy compares
| Official | Trades | Stocks | Buy share | Days to file |
|---|---|---|---|---|
| Donald Remy | 170 | 38 | 8% | 47 |
| Executive branch, median officialmedian of 22 filers | 53 | 20 | 38% | 63 |
| Congress, median membermedian of 127 filers | 126 | 37 | 50% | 27 |
| Most active in Congress, past 12 months: Gilbert Cisneros | 2,699 | 710 | 57% | 27 |
Every disclosed trade
All 170 rows, newest trade first. Amounts are the ranges the form discloses; each links to its source report.
| Traded | Filed | Asset | Type | Amount |
|---|---|---|---|---|
| 2023-01-04 | 2023-03-25 | 07/15/33-CA JJ See Endnote | Purchase | $1,001 - $15,000 |
| 2023-01-04 | 2023-03-25 | CROWN POINT IND MULTI-SCH BLDG REV 5% 07/15/33-CA JJ See Endnote | Purchase | $1,001 - $15,000 |
| 2023-01-04 | 2023-03-25 | JJ See Endnote | Purchase | $1,001 - $15,000 |
| 2023-01-04 | 2023-03-25 | MARICOPA CNTY ARIZ UNI SCH GO 5% 07/01/28 JJ See Endnote | Purchase | $1,001 - $15,000 |
| 2023-01-03 | 2023-03-25 | See Endnote | Exchange | $15,001 - $50,000 |
| 2022-12-29 | 2023-02-22 | SHOP | Sale | $1,001 - $15,000 |
| 2022-09-27 | 2022-12-06 | CHWY | Sale | $1,001 - $15,000 |
| 2022-09-06 | 2024-03-29 | IDV iShares International Select Dividend ETF | Purchase | $15,001 - $50,000 |
| 2022-09-06 | 2024-03-29 | IJH iShares Core S&P Mid-Cap ETF | Purchase | $15,001 - $50,000 |
| 2022-09-06 | 2024-03-29 | IWM iShares Russell 2000 ETF | Purchase | $15,001 - $50,000 |
| 2022-09-06 | 2024-03-29 | JPMorgan Equity Premium Income Fund Class I Shares | Purchase | $15,001 - $50,000 |
| 2022-09-06 | 2024-03-29 | Shares | Purchase | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Artisan International Value Fund Institutional Shares | Purchase | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Emerging Markets Fund Class R6 Shares | Sale | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | JPMorgan Large Cap Growth Fund Class R6 Shares | Sale | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | JPMorgan Large Cap Value Fund Class R6 Shares | Purchase | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | JPMorgan Mid Cap Growth Fund Class R6 Shares | Sale | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Shares | Purchase | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Shares | Sale | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Vanguard International Growth Fund Admiral Shares | Sale | $15,001 - $50,000 |
| 2022-09-02 | 2024-03-29 | Wells Fargo Discovery Fund Class R6 Shares | Sale | $15,001 - $50,000 |
| 2022-08-30 | 2022-10-21 | Indiana State Finance Authority Rev 5% See Endnote | Purchase | $15,001 - $50,000 |
| 2022-07-06 | 2022-09-02 | Vermont St. Gov 5% 08/15/31 FA See Endnote | Purchase | $1,001 - $15,000 |
| 2022-06-27 | 2022-09-02 | TCNNF | Sale | $1,001 - $15,000 |
| 2022-06-27 | 2022-07-26 | RGR Sturm, Ruger & Co., Inc. | Sale | $1,001 - $15,000 |
Showing 25 of 170
Questions people ask
Does Remy have to disclose stock trades?
Yes. Senior executive-branch officials, including the President, must report securities transactions over $1,000 on OGE Form 278-T, generally within 45 days of the trade. The Office of Government Ethics publishes the reports.
How many stock trades has Remy disclosed?
Tracked Money has read 170 transactions from 13 OGE 278-T reports posted between 23 Nov 2021 and 29 Mar 2024, with trade dates from 7 Oct 2021 to 4 Jan 2023.
What stocks does Remy own?
The 278-T lists transactions, not holdings. The stocks traded most often in these reports are Ascendis Pharma A/S (ASND), Apple Inc. (AAPL), Meta Platforms, Inc. (META), Boston Scientific Corp (BSX), Amazon Com Inc (AMZN). Holdings appear on the annual OGE Form 278e financial disclosure, which this page does not cover.
How quickly do Remy's trades become public?
The median trade on this page became public 47 days after it happened, measured from the trade date to the day OGE posted the report. Amounts are disclosed as ranges, not exact figures.
Method and sources
Every row on this page is read from an OGE Form 278-T periodic transaction report published by the U.S. Office of Government Ethics. The reports are scanned or e-filed PDFs; Tracked Money reads each row's asset, type, trade date and amount range, and matches company names to ticker symbols. Rows it cannot match (bonds, funds, unmatched names) are kept with the name as filed. The filing date is the day OGE posted the report, the first day anyone could read it.
- OGE officials' individual disclosures search
- Donald Remy's 13 reports:29 Mar 2024 (14 rows) · 25 Mar 2023 (5 rows) · 25 Mar 2023 (5 rows) · 22 Feb 2023 (1 rows) · 6 Dec 2022 (1 rows) · 6 Dec 2022 (1 rows) · 21 Oct 2022 (1 rows) · 21 Oct 2022 (1 rows) · 2 Sep 2022 (2 rows) · 2 Sep 2022 (2 rows) · 26 Jul 2022 (3 rows) · 23 Nov 2021 (1 rows) · 23 Nov 2021 (142 rows)
Last checked
28 Sep 2026Last time Tracked Money checked OGE for new 278-T reports.
Reports read
13 of 13Every report OGE has posted as a PDF for this official. 13 yielded transaction rows, posted 23 Nov 2021 to 29 Mar 2024.
Tickers matched
133 of 170Rows matched to a ticker symbol. The rest are listed by name and left out of the charts.
Reports OGE releases only on written request (Form 201) are not included. Amounts are statutory ranges, not exact figures. The page is generated from the filing data; the wording is templated, not written per report.